D&D Pharmatech
347850.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
9
Cost of Revenue
0
Gross Profit
9
Gross Margin
100.0%
Operating Income
-19
Operating Margin
-218.7%
Net Income
-21
Net Margin
-250.3%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-18
EBITDA Margin
-211.7%
2023
12/31/2023
Revenue
14
Cost of Revenue
0
Gross Profit
14
Gross Margin
100.0%
Operating Income
-10
Operating Margin
-72.2%
Net Income
3
Net Margin
21.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-48.5%
2022
12/31/2022
Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
94.9%
Operating Income
-51
Operating Margin
-11244.1%
Net Income
-102
Net Margin
-22285.3%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-41
EBITDA Margin
-8994.0%
2021
12/31/2021
Revenue
1
Cost of Revenue
0
Gross Profit
1
Gross Margin
98.1%
Operating Income
-57
Operating Margin
-5547.7%
Net Income
-51
Net Margin
-5001.4%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-48
EBITDA Margin
-4675.3%
2020
12/31/2020
Revenue
0
Cost of Revenue
0
Gross Profit
-0
Gross Margin
N/A
Operating Income
-44
Operating Margin
N/A
Net Income
-48
Net Margin
N/A
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-43
EBITDA Margin
N/A